Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 2/20 | 0.38 |
| ▸ | AKT1 | P31749 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.30 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3474149 | 0.91 | CDC25A (0.37) | CDC25AAKT1LMNAESR1ADORA3 | |
| Diethyl Hydrogen Phosphate SCHEMBL3470090 | 0.91 | LMNA (0.30) | CDC25AAKT1LMNAESR1ADORA3 | |
| SCHEMBL3470365 | 0.85 | CDC25A (0.38) | CDC25AAKT1LMNAESR1ADORA3 | |
| Hydrochloric Acid SCHEMBL2933737 | 0.80 | HRH3 (0.32) | — | |
| Iodide SCHEMBL6005797 | 0.80 | HRH3 (0.32) | — | |
| SCHEMBL16700775 | 0.79 | ALDH1A1 (0.31) | — | |
| Sulfuric Acid SCHEMBL6005800 | 0.79 | CA2 (0.33) | KCNH2 | |
| SCHEMBL3472692 | 0.78 | — | — | |
| SCHEMBL2321702 | 0.78 | CDC25A (0.39) | CDC25AAKT1LMNAESR1ADORA3 | |
| Diethyl Hydrogen Phosphate SCHEMBL3469560 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8287627-B2 | Piperazinium trifluoroacetate compound and carbon dioxide absorbent using the same | HYUNDAI MOTOR COMPANY (KR) | 2012-10-16 | — | — | US | claimed |
| US-20100326277-A1 | PIPERAZINIUM TRIFLUOROACETATE COMPOUND AND CARBON DIOXIDE ABSORBENT USING THE SAME | HYUNDAI MOTOR COMPANY (KR) | 2010-12-30 | — | — | US | claimed |
| US-8287627-B2 | Piperazinium trifluoroacetate compound and carbon dioxide absorbent using the same | HYUNDAI MOTOR COMPANY (KR) | 2012-10-16 | — | — | US | disclosed |
| US-20100326277-A1 | PIPERAZINIUM TRIFLUOROACETATE COMPOUND AND CARBON DIOXIDE ABSORBENT USING THE SAME | HYUNDAI MOTOR COMPANY (KR) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100326277-A1 | PIPERAZINIUM TRIFLUOROACETATE COMPOUND AND CARBON DIOXIDE ABSORBENT USING THE SAME | SLC16A7, SLC16A1, SLC16A3 | CDC25A 1914/4885AKT1 3323/4885LMNA 4277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.